Studies of dehydroepiandrosterone (DHEA) with the human estrogen receptor in yeast

Molecular and Cellular Endocrinology

Volumn 143, Issue 1-2, 1998, Pages 133-142

  Nephew, Kenneth P ^a   Sheeler, Cameron Q ^b   Dudley, Mark D ^c   Gordon, Sheri ^b   Nayfield, Susan G ^d   Khan, Sohaib A ^b  

^a Indiana University School of Medicine   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c SANOFI   (France)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Dehydroepiandrosterone; Estradiol; Estrogen receptor; Hormone; Yeast

Indexed keywords

ANDROSTENEDIOL; ANDROSTENEDIONE; BETA GALACTOSIDASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; HYBRID PROTEIN; PRASTERONE; TESTOSTERONE;

ARTICLE; CONTROLLED STUDY; DIMERIZATION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSIVE ELEMENT; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION; YEAST;

DEHYDROEPIANDROSTERONE; ESTROGENS; HUMANS; RECEPTORS, ESTROGEN; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0032566335     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00128-2     Document Type: Article

References (72)

1. Arbuckle, N.D., Dauvois, S., Parker, M.G., 1992. Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro. Nucleic Acids Res. 20, 3839-3844.
2. Barrett-Connor, E., Goodman-Gruen, D., 1995. The epidemiology of DHEAS and cardiovascular disease. In: Bellino, F.L., Daynes, R.A., Hornsby, P.J., Lavrin, D.H., Nestler, J.E. (Eds.), Dehydroepiandrosterone (DHEA) and Aging, vol. 774, pp. 259-270.
3. Baulieu, E.E., Emiliozzi, R., Lebeau, M.C., Corpechot, C., Robel, P., 1966. Studies of the secretion and the metabolism of steroid conjugates: synthesis, analysis, and use of doubly labeled compounds. Adv. Tracer Methodol. 3, 285-299.
4. Belanger, A., Candas, B., Dupont, A., Cusan, L., Diamond, P., Gomez, J.L., Labrie, F., 1994. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J. Clin. Endocrinol. Metab. 79, 1086-1090.
5. Berr, C., LaFont, S., Debuire, B., Dartigues, J.-F., Baulieu, E.-E., 1996. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study. Proc. Natl. Acad. Sci. USA 93, 13410-13415.
6. Boccuzzi, G., Aragno, M., Brignardello, E., Tamagno, E., Conti, G., Di Monaco, M., Racca, S., Danni, O., Di Carlo, F., 1992. Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Anticancer Res. 12, 1479-1483.
7. Burshell, A., Stathis, P.A., Do, Y., Miller, S.C., Fieldman, D., 1984. Characterization of an estrogen-binding protein in yeast saccharomyces cerevisiae. J. Biol. Chem. 259, 3450-3456.
8. Carlstrom, K., Brody, S., Lunnell, N.O., Lagrelius, A., Mollerstrom, G., Pousette, A., Rannevik, G., Stege, R., von Schoultz, B., 1988. Dehydroepiandrosterone sulfate and dehydroepiandrosterone in serum: differences related to age and sex. Maturitas 10, 297-306.
9. Cavailles, V., Dauvois, S., Danielian, P.S., Parker, M.G., 1994. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA 61, 10009-10013.
10. Cavailles, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P.J., Parker, M.G., 1995. Nuclear factor RIP 140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14, 3741-3751.
11. Chakravarti, D., LaMorte, V.J., Nelson, M.C., Nakajima, T., Schulman, I.G., Juguilon, H., Montminy, M., Evans, R.M., 1996. Role of CBP/P300 in nuclear receptor signaling. Nature 383, 99-103.
12. 50) of an enzymatic reaction. Biochem. Pharmsco. 22, 3099-3108.
13. Chuang, F.M., West, B.L., Baxter, J.D., Schaufele, F., 1997. Activities in Pit-1 determine whether receptor interacting protein 140 activates or inhibits Pit-1/nuclear receptor transcriptional synergy. Mol. Endocrinol. 11, 1332-1341.
14. Fieldman, D., Tokes, L.G., Stathis, P.A., Miller, S.C., Kurz, W., Harvey, D., 1984. Identification of 17β-estradiol as the estrogenic substance in saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 81, 4722-4726.
15. Fields, S., Song, O.-k., 1989. A novel genetic system to detect protein-protein interactions. Nature 340, 245-246.
16. Fields, S., Sternglanz, R., 1994. The yeast two hybrid system: an assay for protein-protein interactions. Trends Genet. 10, 286-292.
17. Gill, G., Ptashne, M., 1987. Mutants of GAL4 protein altered in an activation function. Cell 51, 121-126.
18. Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C., Brown, M., 1994. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264, 1455-1458.
19. Hanstein, B., Eckner, R., DiRenzo, J., Halachmi, S., Liu, H., Searcy, B., Kurokawa, R., Brown, M., 1996. p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. USA 15, 11540-11545.
20. Hasegawa, S., Tanaka, S., Hishinuma, F., Kurata, S.-i., 1991. Estrogen delays entry of the yeast saccharomyces cerevisiae into meiosis. Cell Stuct. Funct. 16, 195-201.
21. Herrington, D.M., 1995. Dehydroepiandrosterone and coronary atherosclerosis. In: Bellino, F.L., Daynes, R.A., Hornsby, P.J., Lavrin, D.H., Nestler, J.E. (Eds.), Dehydroepiandrosterone (DHEA) and Aging, vol. 74, pp. 271-280.
22. Hong, H., Kohli, K., Trivedi, A., Johnson, D.L., Stallcup, M.R., 1996. Grip1, a novel mouse protein that serves as a transcriptional activator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. USA 93, 4948-4952.
23. Hornsby, P.J., 1995. Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. In: Bellino, F.L., Daynes, R.A., Hornsby, P.J., Lavrin, D.H., Nestler, J.E. (Eds.), Dehydroepiandrosterone (DHEA) and Aging, vol. 774, pp. 29-46.
24. Inano, H., Ishii-Ohba, H., Suzuki, K., Yamanouchi, H., Onoda, M., Wakabayashi, K., 1995. Chemoprevention by dietary dehydroepiandrosterone against promotion/proression phase of radiation-induced mammary tumorigenesis in rats. J. Steroid Biochem. Mol. Biol. 11, 193-202.
25. Jesse, R.L., Loesser, K., Eich, D.M., Qian, Y.Z., Hess, M.L., Nestler, J.E., 1995. Dehydroepiandrosterone inhibits human platelet aggregation in Vitro and in Vivo. In: Bellino, F.L., Daynes, R.A., Hornsby, P.J., Lavrin, D.H., Nestler, J.E. (Eds.), Dehydroepiandrosterone (DHEA) and Aging, vol. 774.
26. Joyeux, A., Cavailles, V., Balaguer, P., Nicolas, J.C., 1997. RIP 140 enhances nuclear receptor-dependent transcription in vivo in yeast. Mol. Endocrinol. 11, 193-202.
27. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.C., Heyman, R.A., Rose, D.W., Glass, C.K., Rosenfeld, M.G., 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
28. Katzenellenbogen, B.S., Bhardwaj, B., Fang, H., Ince, B.A., Pakdel, F., Reese, J.C., Schodin, D.J., Wrenn, C.K., 1993. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems. J. Steroid Biochem. Mol. Biol. 47, 39-48.
29. Kohno, H., Gandini, O., Curtis, S.W., Korach, K.S., 1994. Anti-estrogen activity in the yeast transcription system: estrogen receptor mediated agonist response. Steroids 59, 572-578.
30. Kuiper, G.G.J., Enmark, E., Pelto-Huikko, M., Nilsson, S., Gustafsson, J.-A., 1996. Cloning a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93, 5925-5930.
31. Kuiper, G.G.J.M., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., Gustafsson, J.-A., 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138, 863-870.
32. Labrie, F., 1991. Intracrinology. Mol. Cell Endocrinol. 78, 113-118.
33. Labrie, F., Belanger, A., Simard, J., Luuthe, V., Labrie, C., 1995. DHEA and peripheral androgen and estrogen formation: intracrinology. In: Bellino, F.L., Daynes, R.A., Hornsby, P.J., Lavrin, D.H., Nestler, J.E. (Eds.), Dehydroepiandrosterone (DHEA) and Aging, vol. 774, pp. 16-28.
34. LeDouarin, B., Zechel, C., Garnier, J.M., Lutz, Y., Tora, L., Pierrat, P., Heery, D., Gronemeyer, H., Chambon, P., Losson, R., 1995. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14, 2020-2033.
35. Lee, J.W., Ryan, F., Swaffield, J.C., Johnston, S.A., Moore, D.D., 1995. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374, 91-94.
36. L'Horset, F., Dauvois, S., Heery, D.M., Cavailles, V., Parker, M.G., 1996. RIP-140 Interacts with multiple nuclear receptors by means of two distinct sites. Mol. Cell. Biol. 16, 6029-6036.
37. Lin, J.T., Heftmann, E., 1982. Comparison of adsorption and reversed-phase partition high-performance liquid chromatography for the separation of androgens. J. Chromatogr. 237, 215-224.
38. Longcope, C., 1995. Metabolism of dehydroepiandrosterone. In: Bellino, F.L., Daynes, R.A., Hornsby, P.J., Lavrin, D.H., Nestler, J.E. (Eds.), Dehydroepiandrosterone (DHEA) and Aging, vol. 774, pp. 143-148.
39. Luo, S., Labrie, C., Belanger, A., Labrie, F., 1997. Effect of dheydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the rat. Endocrinology 138, 3387-3394.
40. Lyttle, C.R., Damian-Matsumura, P., Juul, H., Butt, T.R., 1992. Human estrogen receptor regulation in a yeast model system and studies on receptor agonists and antagonists. J. Steroid Biochem. Mol. Biol. 7, 677-685.
41. Ma, J., Ptashne, M., 1988. Converting a eukaryotic transcriptional inhibitor into an activator. Cell 55, 443-446.
42. Majewska, M.D., 1995. Neuronal actions of dehydroepiandrosterone. Possible roles in brain development, aging, memory, and affect. In: Bellino, F.L., Daynes, R.A., Hornsby, P.J., Lavrin, D.H., Nestler, J.E. (Eds.), Dehydroepiandrosterone (DHEA) and Aging, vol. 774.
43. McCormick, D.L., Rao, K.V.N., Bosland, M.C., Steele, V.E., Lubet, R.A., Kelloff, G.J., 1995. Inhibition of rat prostatic carcinogenesis by dietary dehydroepiandrosterone but not by N-(4-hydroxphenyl)retinamide. Proc. Am. Assoc. Cancer Res. 36, 126.
44. McCormick, D.L., Rao, K.V.N., Johnson, W.D., Bowman-Gram, T.A., Steele, V.E., Lubet, R.A., Kelloff, G.J., 1996. Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland. Cancer Res. 56, 1724-1726.
45. Milewich, L., Catalina, F., Bennett, M., 1995. Pleotropic effects of dietary DHEA. In: Bellino, F.L., Daynes, R.A., Hornsby, P.J., Lavrin, D.H., Nestler, J.E. (Eds.), Dehydroepiandrosterone (DHEA) and Aging, vol. 774, pp. 149-170.
46. Moore, M.A., Thamavit, W., Tsuda, H., Sato, K., Ichihara, A., Ito, N., 1986. Modifying influence of dehydroepiandrosterone on the development of dihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung, and liver of F344 rats. Carcinogenesis (London) 7, 311-316.
47. Morales, A.J., Nolan, J.J., Nelson, J.C., 1994. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78, 1360-1367.
48. Nyce, J.W., Magee, P.N., Hard, G.C., Schwartz, A.G., 1984. Inhibition of 1,2-dimethylhgydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. Carcinogenesis (London) 5, 57-62.
49. Onate, S.A., Tsai, S.Y., Tsai, M.-J., O'Malley, B.W., 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357.
50. Orentreich, N., Brind, J.L., Rizer, R.L., Vogelman, J.H., 1984. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 59, 551-555.
51. Orentreich, N., Brind, J.L., Vogelman, J.H., 1992. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J. Clin. Endocrinol. Metab. 75, 1002-1004.
52. Pashko, L.L., Rovito, R.J., Williams, J.R., Sobel, E.L., Schwartz, A., 1984. Dehydroepiandrosterone (DHEA) and 3β-methylandrost-5-en-17-one: inhibitors of 7, 12-dimethylbenz(a)anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA) promoted skin papilloma formation in mice. Carcinogenesis (London) 5, 463-466.
53. Pashko, L.L., Hard, G.C., Rovito, R.J., Williams, J.R., Sobel, E.L., Schwartz, A.G., 1985. Dehydroepiandrosterone (DHEA) and 3β-methylandrost-5-en-17-one inhibit 7,12-dimethylbenz(a) anthracene (DMBA)-induced skin papillomas and carcinomas in mice. Cancer Res. 45, 164-166.
54. Poortman, J., Vroegindewey-Jie, D., Thijssen, J.H., Schwarz, F., 1977. Relative binding affinity of androstane and C-19-nor-androstane-steroids for the estradiol-receptor in human myometrial and mammary cancer tissue. Mol. Cell. Endocrinol. 1, 27-34.
55. Ratko, T.S., Detrisac, C.J., Mehta, R.G., Kelloff, G.J., Moon, R.C., 1991. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone. Cancer Res. 51, 481-486.
56. Schwartz, A.G., 1979. Inhibition of spontaneous breast cancer formation in female C3H(A vy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res. 39, 1129-1132.
57. Schwartz, A.G., Tannen, R.H., 1981. Inhibition of 7,12-dimethylbenz(a)anthracene-induced lung adenomas in A/J mice by long term treatment with dehydroepiandrosterone. Carcinogenesis (London) 2, 1335-1337.
58. Schwartz, A.G., Pashko, L.L., 1995a. Mechanism of cancer preventive action of DHEA. In: Bellino, F.L., Daynes, R.A., Hornsby, P.J., Lavrin, D.H., Nestler, J.E. (Eds.), Dehydroepiandrosterone (DHEA) and Aging, vol. 774, pp. 180-186.
59. Schwartz, A.G., Pashko, L.L., 1995b. Cancer prevention with dehydroepiandrosterone and non-androgenic structural analogs. J. Cell. Biochem. Suppl 22, 210-217.
60. Sheeler, C.Q., Dudley, M.D., Wang, H., Khan, S.A., 1998. The environmental estrogens octylphenol, bisphenol-A, and o,p'-DDT promote human estrogen receptor dimerization and stimulate transcription activity in two yeast genetic systems. Environmental. Health Perspectives, In press.
61. Sikorski, R.S., Hieter, P., 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122, 19-27.
62. Sulcova, J., Hill, M., Starka, L., 1997. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J. Endocrinol. 154, 57-62.
63. Tan, J., Sharief, Y., Hamil, K.G., Gregory, C.W., Zang, D.-Y., Sar, M., Gumerlock, P.H., White, R.W., Pretlow, T.G., Harris, S.E., Wilson, E.M., Mohler, J.L., French, F.S., 1997. Dehydroepiandrosterone activities mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP Cells. Mol. Endocrinol. 11, 450-459.
64. Tsai, M.J., O'Malley, B.W., 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486.
65. Vande Weile, R., Lieberman, S., 1960. The metabolism of dehydroisoandrosterone. In: Pincus, G., Vollmer, E. (Eds.), Biological Activity of Steroids in Relation to Cancer, pp. 93-110.
66. Van den Brink, H.J.M., van Gorcom, R.F.M., van den Hondel, C.A.M.J.J., Punt, P.J., 1998. Cytochrome P450 enzyme systems in fungi. Fungal Genet. Biol. 23, 1-17.
67. Vermeulen, A., 1995. Dehydroepiandrosterone sulfate and aging. In: Bellino, F.L., Daynes, R.A., Hornsby, P.J., Lavrin, D.H., Nestler, J.E. (Eds.), Dehydroepiandrosterone (DHEA) and Aging, vol. 774, pp. 121-127.
68. Voegel, J.J., Heine, M.J.S., Zechel, C., Chambon, P., Gronemeyer, H., 1996. TIF2, a 160 dDA transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15, 101-108.
69. Vom Baur, E., Zechel, C., Heery, D., Heine, M.J., Garnier, J.M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P., Losson, 1996. Differential ligand-dependent interactions between the AF-2 ctivating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1, EMBO J. 15, 110-124.
70. Wang, H., Peters, G., Xin, Z., Tang, M., Ip, W., Khan, S., 1995. Yeast two-hybrid system demonstrates that estrogen receptor dimerization is ligand-dependent in vivo. J. Biol. Chem. 270, 23322-23329.
71. Wang, H., Khan, S.K., 1998. Analysis of ER variants using the yeast two-hybrid system, Endocrinology, (In press).
72. Yao, T.-P., Ku, G., Zhou, N., Scully, R., Livingston, D.M., 1996. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300, Proc. Natl. Acad. Sci. USA. 93, 10626-10631.